Product Information
DORZOLAMIDE HCL 2% EYE DROPS is a generic product labeled by Florida Pharmaceutical Products, LLC, priced at $0.8575 per ML under NDC 71921040010. Its NADAC has been published 39 times since Oct 1, 2025.
Strength
20 mg/mL
Manufacturer
Florida Pharmaceutical Products, LLCNDC
71921040010
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
DORZOLAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202053On Market Since
5/7/2025
Pharmacological Classes
Price Statistics
The NADAC for DORZOLAMIDE HCL 2% EYE DROPS has been published 39 times since Oct 1, 2025, and over the history we have for it it has declined 13.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8575 per ML |
|---|---|
| All-time high | $0.9950 (Oct 15, 2025) |
| All-time low | $0.8554 (May 20, 2026) |
| 52-week high | $0.9950 |
| 52-week low | $0.8554 |
| Median price | $0.9239 |
| Average price | $0.9116 |
| Largest weekly change | -5.6% (Oct 22, 2025) |
| Weeks tracked | 39 |
| Tracking since | Oct 1, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Dorzolamide Hydrochloride Ophthalmic market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DORZOLAMIDE HCL 2% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE HCL 2% EYE DROPS, manufactured by Florida Pharmaceutical Products, LLC, is $0.8575 per ML (NDC 71921040010), effective Jun 24, 2026.
How has the price of DORZOLAMIDE HCL 2% EYE DROPS changed over time?
Over the history we have for it, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has declined 13.8%. It has been tracked across 39 weekly CMS publications since Oct 1, 2025.
What are the highest and lowest recorded NADAC prices for DORZOLAMIDE HCL 2% EYE DROPS?
Since Oct 1, 2025, the NADAC for DORZOLAMIDE HCL 2% EYE DROPS has ranged from a low of $0.8554 (May 20, 2026) to a high of $0.9950 (Oct 15, 2025), with a median of $0.9239 per ML.
Are there cheaper alternatives to DORZOLAMIDE HCL 2% EYE DROPS?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DORZOLAMIDE HCL 2% EYE DROPS, so no direct lower-cost alternative is listed.
Who manufactures DORZOLAMIDE HCL 2% EYE DROPS?
DORZOLAMIDE HCL 2% EYE DROPS (NDC 71921040010) is labeled by Florida Pharmaceutical Products, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification